You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動 | 沛嘉醫療-B(9996.HK)首日上市高開74.48%
格隆匯 05-15 09:29
格隆匯5月15日丨國內醫療器械研發商沛嘉醫療-B(9996.HK)首日上市高開74.48%,報26.8港元,暫成交6.8億港元,最新總市值163億港元。沛嘉醫療主要覆蓋中國各經導管瓣膜治療醫療器械市場以及神經介入手術醫療器械市場,是中國市場僅有的四名擁有處於臨牀試驗或更後期階段經導管主動脈瓣置換術(“TAVR”)產品國內參與者之一。根據弗若斯特沙利文數據,全球TAVR產品市場由2014年的15億美元增至2018年的41億美元,複合年增長率為27.8%,預計到2030年市場規模將達到104億美元。公司本次發行1.525億股,每股定價15.36港元,每手1000股,香港公開發售部分錄得超額認購1183.41倍,一手中籤率8.5%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account